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 This study involve development of a simple, sensitive, precise, accurate and economic HPLC 
method and two UV methods for simultaneous estimation of phenylephrine HCl (Phe) and 
ketorolac tromethamine (Ket). The UV methods are based upon absorption correction and 
multicomponent analysis approach. Wavelength maxima (λmax) selected for Phe and Ket were 
273 nm and 323 nm respectively. Selected linearity ranges for Phe and Ket were 12-42 ppm 
and 4-14 ppm respectively for UV methods. HPLC method was developed using Waters 
HILIC (Hydrophilic interaction liquid chromatography) column having dimension of 150 mm 
x 4.6 mm, 5 μm. Mobile phase used was acetate buffer (pH 3.2; 10mM): MeOH: ACN:: 
32:23:45 with flow rate of 1mL/min at detection wavelength of 275nm. Retention time for 
Phe and Ket were 2.96 and 1.96 min. Linearity ranges for Phe and Ket chosen were 30-60 and 
10-20 µg/mL respectively for HPLC method. Thus, selective and robust spectrophotometric 
and chromatographic methods were developed successfully and also validated for various 
parameters like accuracy, precision (intra-day and inter-day), linearity and range, limit of 
detection and limit of quantitation (LOD and LOQ) as per ICH guidelines. %Assay was also 
determined and found to be in accordance with the label claim. Both the developed methods 
are quite sensitive for simultaneous identification and analysis of Phe and Ket in bulk. 
Please cite this article in press as Prof. (Mrs.) Sadhana J. Rajput et al. Simultaneous Estimation of Phenylephrine Hydrochloride 
and Ketorolac Tromethamine Using UV Spectrophotometric and HPLC Methods. Indo American Journal of Pharmaceutical 
Research.2017:7(01). 
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INTRODUCTION 
Chemically, Ketorolac (Ket) is (-)-5-Benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-1-carboxylic acid (Figure 1 A).  It is a 
non-steroidal anti-inflammatory agent with potent analgesic activity. Usually it is administered orally as its tromethamine salt having 
potent cyclooxygenase inhibitory activity therefore used as analgesic and anti-inflammatory moiety. Available clinical data indicates 
that a single dose of Ket is as effective as of aspirin and paracetamol and much more effective than that of morphine and pethidine [1].  
Chemically, phenylephrine HCl (Phe) is (R)-1-(3-hydroxy phenyl)-2-methylamino ethanol hydrochloride (Figure 1 B). It is 
alpha-1 adrenoreceptor agonist and used as a decongestant [2].  
OMIDRIA
®
 a fixed dose combination of Ket and Phe is used as mydriatic agent i.e. eye irrigating solution during cataract surgery [3]. 
 
(A)  
      (B) 
 
 
 
Figure-1: Structure of (A) Ketorolac Tromethamine (Ket); (B) Phenylephrine HCl (Phe). 
 
In this study, two UV methods were developed for simultaneous estimation of Phe and Ket. Absorption correction method is 
used if the sample contains two absorbing drugs (X and Y), one of which (X) absorbs at the λmax of other (Y) but other (Y) shows zero 
absorbance at λmax of first (X) then, it may be possible to determine both the drug by simplified simultaneous equation method using 
following formula [4]. 
A1=aX1*Cx + aY1*Cy 
A2= aX2*Cx + aY2*Cy 
 
Where, A1 and A2 = Absorbances of the mixture at λ1 and λ2 respectively; aX1=absorptivity of X at λ1 nm; 
aX2=absorptivity of X at λ2 nm; aY1=absorptivity of Y at λ1 nm; aY2= absorptivity of Y at λ2 nm; Cx =concentration of X; Cy =  
concentration of Y. 
In multi component analysis approach, the concentration of each constituent is determined using absorption spectra of the 
mixed sample with pure standards. It is the most sensitive and accurate measurement technique for simultaneous estimation of drugs. 
Spectral data are promptly acquired with ease and also time consuming prior separation procedures including extraction, concentration 
of constituents and the clean-up steps can be avoided [5]. 
Various spectrophotometric and chromatographic analytical methods are available for determination of both the drugs 
individual [6-25]. Prava, V. and Seru G. have also reported HPLC method for both the drugs simultaneously [26]. But simultaneous 
estimation of Phe and Ket using absorbance correction and multicomponent quantitation UV methods; and by HPLC method using 
HILIC column have not yet been reported. Thus, the main objective to carry out present study is to develop a simple, accurate, precise, 
specific, sensitive and robust UV spectrophotometric and HPLC methods.  
 
MATERIALS AND METHODS 
Chemicals and reagents: 
Phe and Ket reference standards were purchased from Sigma Aldrich, Bengaluru, India. Because of the unavailability of the 
marketed formulation OMIDRIA
® 
in a local market, a laboratory mixture of Phe and Ket was prepared in proportion of 3:1. Methanol 
(MeOH) and acetonitrile (ACN) of analytical grade and HPLC grade were obtained from Spectrochem Pvt. Ltd., Mumbai India. Other 
reagents like ammonium acetate buffer and acetic acid were procured from Loba Chemie Pvt. Ltd., Mumbai, India.  All the solutions 
were prepared in HPLC grade water and filtered through 0.2 µ millipore membrane filter before injecting into HPLC. 
 
Instrumentation: 
UV spectrophotometer: 
Simultaneous spectrophotometric estimation of Phe and Ket were carried out using Shimadzu UV-1700 double beam 
spectrophotometer equipped with Shimadzu UV Probe 2.10.software. Matched quartz cuvettes of 1 cm was utilized to hold drug 
solution to be analyzed and UV spectrum was recorded over range of 200-400 nm.  
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HPLC 
A simultaneous chromatographic evaluation of Phe and Ket in both bulk and laboratory mixture was performed on Shimadzu, 
Kyoto, Japan equipped with LC-20AT pump, Rheodyne 7725 injector with loop capacity of 20 µL and Shimadzu SPD-20AV detector. 
HPLC column used was HILIC column (150mm x 4.6mm, 5µm).  
 
Preparation of stock solution and working solution (Common for UV and HPLC method):  
Accurately weighed 10 mg of Phe and Ket were individually transferred to 10 mL volumetric flasks and diluted with MeOH 
to get stock solutions of two drugs having 1000 µg/mL concentration. Working solutions of Phe and Ket both having 100 µg/mL 
concentration were prepared from stock solutions by withdrawing 1mL respectively from each and volume was made upto the mark in 
a 10 mL volumetric flask using the same diluent. 
 
Preparation of calibration standards of Phe and Ket 
UV methods I and II: 
From working solutions of 100 µg/mL of Phe and Ket, aliquots of 1.2 mL and 0.4 mL respectively were withdrawn, and 
mixed in 10 mL volumetric flasks and diluted upto the mark with mobile phase. Same procedure was followed for other aliquots of 
1.8, 2.4, 3.0, 3.6, 4.2 mL and of 0.6, 0.8, 1.0, 1.2, 1.4 mL of Phe and Ket respectively. Thus final solutions containing Phe and Ket in 
the ratio of 3:1 were analyzed by UV spectrophotometer at two different wavelength i.e. at 273 nm and 323 nm. 
 
HPLC method: 
From working solutions of 100 µg/mL of Phe and Ket, aliquots of 3.0 mL and 1.0 mL respectively were withdrawn, and 
mixed in 10 mL volumetric flasks and diluted upto the mark with mobile phase. Same procedure was followed for other aliquots of 
3.0, 3.6, 4.2, 4.8, 5.4, 6.0 mL and of 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 mL of Phe and Ket respectively. Thus final solutions containing Phe and 
Ket in the ratio of 3:1 were analyzed by HPLC. 
 
Selection of common analytical wavelength for both APIs: 
Solutions of Phe and Ket were scanned using UV spectrophotometer in range of 200-400 nm. Overlain spectra individually 
of both drug were used for selection of analytical wavelength and 275 nm was selected as analytical wavelength as shown in Figure 2. 
 
 
 
Figure-2: Common Wavelength Selection for Phe (Pink) and Ket (Blue) by UV Spectrophotometry. 
 
Chromatographic procedure: 
HPLC analysis was performed using Waters HILIC column. Different ratio of MeOH, ACN and acetate buffer at the 
different flow rates (0.9, 1.0 and 1.1 mL/min), different buffer pH (3.2, 3.5 and 4.2) at detection wavelength of 275 nm were tried. 
Finally the method was optimized and developed using a ratio 32:23:37 of acetate buffer (pH:3.2, 10mM, 0.05% TEA, filtered through 
0.2µ millipore membrane filter):MeOH:ACN respectively at a flow rate of 1.0 mL/min and detection wavelength of 275 nm as it 
showed symmetric chromatographic peaks for both Phe and Ket within system suitability parameters (table 1).  
 
Table-1. Optimized chromatographic conditions for Phe and Ket. 
 
METHOD PARAMETER OPTIMIZED VALUE 
Column Waters HILIC (150 mm x 4.6 mm, 5 μm) 
Mobile Phase Acetate buffer (pH 3.2):MeOH:ACN::32:23:45 
Flow rate 1.0 mL/min 
Retention Time 1.96 min for Ket and 2.96 min for Phe 
Detection Wavelength 275 nm 
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Validation of developed UV method and HPLC method: 
Developed UV methods were validated for various parameters like accuracy (%recovery), intra-day and inter-day precision, 
linearity and range, LOD (limit of detection) and LOQ (limit of quantitation), robustness according to ICH Q2(R1) guideline. For 
HPLC method, besides this parameters, system suitability parameters were also measured.  
 
RESULTS AND DISCUSSION 
Developed and optimized UV spectrophotometric and chromatographic methods were validated for various parameters 
discussed in following sections. 
 
Linearity and Range: 
 Linearity solutions ranging from concentration of 12-42 and 4-14 µg/mL (for UV methods) and 30-60 and 10-20 µg/mL (for 
HPLC method) for Phe and Ket respectively were prepared and analyzed in triplicate at a constant injection volume of 10 µL. 
Calibration curve and r
2 
value for UV methods (Figure 3) and HPLC method were generated (Figure 4). UV spectra and HPLC 
chromatogram for linearity is depicted in figure 5 and 6 respectively (Table 2 and 3). 
 
 
Figure 3(a) 
 
Figure 3(b) 
 
Figure 3(c) 
 
Figure 3(d) 
 
Figure-3: Calibration Curve For (A) Phe and (B) Ket by Absorbance Correction Method, (C) Phe And (D) Ket by Multi-
Component Analysis Method. 
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Table-2: Validation parameters results for UV methods: 
 
Parameter 
Absorbance Correction Method Multi-component Analysis Method 
Phenylephrine HCl 
Ketorolac 
Tromethamine 
Phenylephrine HCl Ketorolac Tromethamine 
Analytical wavelength(nm) 273nm 323.5nm 273nm 323.5nm 
Linearity range(μg/ml) 12-42 ppm 4-14ppm 12-42 ppm 4-14ppm 
Regression Equation y = 0.008x+0.005 y =0.05x+0.049 y =1.000x - 0.242 y =1.011x - 0.440 
Correlation coefficient 0.997 0.996 0.998 0.999 
LOD (µg/mL) 1.386 1.59 0.737 0.666 
LOQ (µg/mL) 4.05 4.85 2.23 2.01 
Intra-day precision (%RSD) 0.789 1.0082 1.082 1.349 
Inter-day precision (%RSD) 1.02 1.0037 1.235 1.426 
 
Table-3: Validation parameters results for RP-HPLC method: 
 
Parameter HPLC method 
Phenylephrine HCl Ketorolac Tromethamine 
Common Analytical wavelength(nm) for both APIs 275 nm 275 nm 
Linearity range(μg/mL) 30-60 ppm 10-20 ppm 
Regression Equation y = 8.4755x - 125.52 y = 8.1165x - 31.528 
Correlation coefficient 0.9965 0.9977 
LOD (µg/mL) 0.4737 0.565 
LOQ (µg/mL) 1.435 1.712 
Intra-day precision (%RSD) 0.387 1.055 
Inter-day precision (%RSD) 0.714 1.243 
 
(a) 
 
                          
 
(b) 
 
Figure-4: Calibration Curve of (A) Phe (12-42 µg/ml) and Ket (4-14 µg/ml) by HPLC method. 
 
LOD and LOQ (Limit of Detection and Limit of Quantitation) 
LOD and LOQ of both UV and HPLC methods were determined using standard deviation of response and slope of 
calibration curve approach. Six replicates of the drug sample with lowest detectable and quantifiable concentration were injected and 
%RSD was determined (Table 2 and 3). 
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Figure-5: Calibration Curve for Phe and Ket using UV Method. 
 
 
 
Figure-6: Calibration Curve for Phe and Ket using HPLC Method. 
 
Precision (Intra-day Precision and Inter-day Precision): 
Precision was calculated by analysing LQC (low quality control), MQC (medium quality control) and HQC (high quality 
control) in six replicates on same day (intra-day) and at different days (inter-day). Standard deviation (SD) and relative standard 
deviation (%RSD) were calculated (Table 2 and 3).          
 
Accuracy (%Recovery): 
Standard addition method was applied to express accuracy of method to drug sample by spiking known amount of Ket 
and Phe corresponding 80, 100, and 120% i.e. 9.92, 12.4 and 14.88 μg/mL for Phe and 3.39, 4.24 and 5.08 μg/mL for Ket to fixed 
concentration of its laboratory mixture. %Recovery and SD were designed as depicted table 4. 
 
TablE-4: Results of Accuracy for UV and HPLC method. 
 
% 
spiking 
% Recovery*± 
Standard Deviation 
Absorbance Correction Method Multi-component Method RP-HPLC method 
Phe Ket Phe Ket Phe Ket 
80 98.7±0.787 99.52±0.632 100.32±0.348 98.58±0.556 98.79±0.220 97.34±0.858 
100 99.67±0.536 100.23±0.476 99.43±0.186 100.47±0.361 99.19±0.248 98.58±0.742 
120 100.26±0.473 99.68±0.843 99.78±0.214 98.89±0.486 98.79±0.232 99.09±0.912 
 
%Assay: 
%Assay was determined by analysing similar concentration of Phe and Ket solution and laboratory mixture in UV and 
HPLC. The value of % assay was calculated by comparing absorbance (for UV methods) and area of chromatographic peak (for 
HPLC method) of laboratory mixture with drug standard and their results are listed in Table 5. 
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Table-5: % assay of synthetic mixture of Phe and Ket. 
 
APIs 
Labelled 
Claim 
% Assay by Absorption 
Correction method 
% Assay by Multi-component 
Quantitation Mode 
% Assay by RP-
HPLC method 
Phe 12.42 mg 99.54±0.280 99.81± 1.010 98.92± 0.230 
Ket 4.24 mg 99.84±1.41 99.31±0.147309 98.31 ± 0.867 
 
Specificity 
Specificity of the method was demonstrated by injecting the blank solution, standard solution and sample solution 
prepared from laboratory mixture with excipient and responses were determined. There was no interfering peak of any excipient 
in the chromatogram. 
 
Robustness 
Robustness of the method was demonstrated by deliberately changing the chromatographic conditions like pH, grade of 
acetonitrile used and flow rate (table 6). 
 
Table-6: Robustness results for both the method. 
 
Chromatog
raphic 
Condition 
Range 
Chromatographic Parameters 
Retention time (min) Peak Area (mV.sec) 
Phe Ket Phe Ket 
pH (Unit) 
3.1 2.54 
2
.5
5
±
0
.0
1
 1.92 
1
.9
5
±
0
.0
2
 
363.21 
3
6
3
.3
5
 ±
 
0
.1
5
 
146.54 
1
4
6
.8
0
 ±
 
0
.7
8
 3.3 2.56 1.97 363.32 147.12 
3.5 2.57 1.96 363.52 146.80 
Flow Rate 
(mL/min) 
0.9 2.6 
2
.5
5
±
0
.0
5
 
2.1 
1
.9
7
±
0
.1
2
 
360.52 
3
6
5
.2
6
±
1
.1
0
 
149.53 
1
4
8
.4
2
 
±
1
.0
1
 
1.0 2.56 1.96 362.12 148.23 
1.1 2.5 1.86 364.23 147.52 
Buffer 
Ratio (%) 
30:70 2.65 
2
.5
2
±
0
.1
3
 
1.8 
1
.9
2
±
0
.1
0
 360.52 
3
6
2
.2
9
±
1
.8
5
 
147.58 
1
4
6
.6
5
±
1
.6
8
 32:68 2.54 1.96 362.12 146.23 
34:66 2.39 2.01 364.23 148.52 
 
System Suitability Parameters for HPLC method: 
System suitability test was carried out on freshly prepared standard solutions containing Phe and Ket. System suitability 
parameters obtained with 20 μL injection volumes are summarized below table 7. 
 
Table-7: System Suitability Parameters for Phe and Ket. 
 
Parameters Data Obtained
*
 
Phe Ket 
Retention time ± SD 2.56±0.123 1.96 ± 0.075 
Theoretical plate ± SD 2245 ± 12.56 2100 ± 32.563 
Tailing factor ± SD 1.52 ± 0.089 1.79±0.0356 
Resolution ± SD 2.5±0.0789 - 
*Data shown is the average of six replicates. SD= Standard Deviation. 
 
Stability in sample solutions: 
Working solution of Phe and Ket prepared from standard stock solution were kept at room temperature for 24 hrs and then 
they were analysed by developed and optimized UV and HPLC methods. Absence of extra peak confirmed stability of both the drugs 
at room temperature.  
 
CONCLUSION 
The developed UV and HPLC methods for simultaneous estimation of phenylephrine HCl and ketorolac tromethamine were 
sensitive, robust and rapid. Both methods were successfully validated according to ICH Q2 (R1) guidelines. %Assay values obtained 
by UV and HPLC method were within the limit specified by ICH Q2 (R1) guideline. Developed HPLC method is advantageous over 
literature in terms of reduction in chromatographic run time which gave a cheapest HPLC method due to lesser consumption of 
organic solvents which in turn reduce in analysis time. Developed method can be implemented for detection of Phe and Ket in 
biological matrices in future.  
 
ACKNOWLEDGMENT 
The authors thank to The Maharaja Sayajirao University of Baroda for providing a firm platform to carry out such a work. 
 
                                                   
www.iajpr.com 
P
ag
e7
3
8
8
 
Vol 7, Issue 01, 2017.                                          Prof. (Mrs.) Sadhana J. Rajput et al.                                       ISSN NO: 2231-6876 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONFLICT OF INTEREST:  
The authors declare no conflict of interest 
 
ABBREVIATIONS 
Phe : Phenylephrine hydrochloride 
Ket : Ketorolac tromethamine 
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